{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8299665", "DateCompleted": {"Year": "1994", "Month": "03", "Day": "07"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0031-6970", "JournalIssue": {"Volume": "45", "Issue": "4", "PubDate": {"Year": "1993"}}, "Title": "European journal of clinical pharmacology", "ISOAbbreviation": "Eur J Clin Pharmacol"}, "ArticleTitle": "Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack.", "Pagination": {"StartPage": "333", "EndPage": "336", "MedlinePgn": "333-6"}, "Abstract": {"AbstractText": ["A platelet-inhibiting effect is described for garlic. In this double-blind, placebo-controlled study on 60 voluntary subjects with cerebrovascular risk factors and constantly increased platelet aggregation it was demonstrated that the daily ingestion of 800 mg of powdered garlic (in the form of coated tablets) over 4 weeks led to a significant inhibition of the pathologically increased ratio of circulating platelet aggregates and of spontaneous platelet aggregation. The ratio of circulating platelet aggregates decreased by 10.3%, from 1.17 +/- 0.08 to 1.05 +/- 0.11 (P < 0.01), and spontaneous platelet aggregation by 56.3%, from 40.7 +/- 23.3 to 17.8 +/- 23.2 degrees (P < 0.01) during the garlic phase. There were no significant changes in the placebo group. The parallel group comparison (garlic versus placebo) revealed a significantly different ratio of circulating platelet aggregates after 4 weeks of treatment (P < 0.05). After the 4-week wash-out phase the values increased again to 1.19 +/- 0.32 and 34.9 +/- 28.7 degrees, reaching the initial values (run-in phase prior to the ingestion of garlic). Since garlic is well tolerated it would be worth testing it in a controlled clinical trial for usefulness in preventing disease manifestations associated with platelet aggregation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Haemostasiology and Transfusion Medicine, University of the Saarland, Homburg/Saar, Germany."}], "LastName": "Kiesewetter", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jung", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jung", "ForeName": "E M", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mroweitz", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Koscielny", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wenzel", "ForeName": "E", "Initials": "E"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Eur J Clin Pharmacol", "NlmUniqueID": "1256165", "ISSNLinking": "0031-6970"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Tablets"}], "MeshHeadingList": [{"QualifierName": ["prevention & control"], "DescriptorName": "Brain Ischemia"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Garlic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Platelet Aggregation"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": [], "DescriptorName": "Tablets"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Klin Wochenschr. 1988 Nov 15;66(22):1110-5", "ArticleIdList": ["3148788"]}, {"Citation": "Prog Cardiovasc Dis. 1979 Jan-Feb;21(4):255-66", "ArticleIdList": ["154121"]}, {"Citation": "Dtsch Med Wochenschr. 1983 May 20;108(20):775-8", "ArticleIdList": ["6840009"]}, {"Citation": "Acta Neurol Scand. 1977 Jan;55(1):76-82", "ArticleIdList": ["842281"]}, {"Citation": "Int Angiol. 1986 Jul-Sep;5(3):181-95", "ArticleIdList": ["3104511"]}, {"Citation": "Artery. 1980;7(5):428-37", "ArticleIdList": ["7213027"]}, {"Citation": "Thromb Res. 1986 Dec 15;44(6):793-806", "ArticleIdList": ["3798421"]}, {"Citation": "Acta Neurol Scand. 1977 Oct;56(4):326-34", "ArticleIdList": ["920111"]}, {"Citation": "Br Med J (Clin Res Ed). 1985 May 18;290(6480):1453-6", "ArticleIdList": ["3922531"]}, {"Citation": "Fortschr Neurol Psychiatr. 1985 Sep;53(9):350-3", "ArticleIdList": ["4043916"]}, {"Citation": "Clin Investig. 1993 May;71(5):383-6", "ArticleIdList": ["8508009"]}, {"Citation": "Vasa. 1990;19(4):286-95", "ArticleIdList": ["2291307"]}, {"Citation": "Lancet. 1974 Oct 19;2(7886):924-6", "ArticleIdList": ["4138914"]}, {"Citation": "Lancet. 1981 Jan 17;1(8212):150-1", "ArticleIdList": ["6109819"]}, {"Citation": "Atherosclerosis. 1978 Aug;30(4):355-60", "ArticleIdList": ["708492"]}, {"Citation": "Br J Clin Pharmacol. 1989 Nov;28(5):535-44", "ArticleIdList": ["2686739"]}, {"Citation": "Biomed Tech (Berl). 1985 Jun;30(6):152-8", "ArticleIdList": ["4016179"]}, {"Citation": "Atherosclerosis. 1988 Dec;74(3):247-9", "ArticleIdList": ["3240334"]}, {"Citation": "Arch Dermatol Res. 1983;275(4):229-34", "ArticleIdList": ["6625648"]}, {"Citation": "J Clin Invest. 1975 Sep;56(3):624-32", "ArticleIdList": ["1159076"]}, {"Citation": "Prev Med. 1987 Sep;16(5):670-85", "ArticleIdList": ["3317392"]}, {"Citation": "Eur Neurol. 1983;22(6):437-41", "ArticleIdList": ["6363086"]}], "ReferenceList": []}], "History": [{"Year": "1993", "Month": "1", "Day": "1"}, {"Year": "1993", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8299665", "10.1007/BF00265950"]}}]}